Jarir Logo

Nitroglycerin Sustained Release Tablet. Formulation Design and Evaluation

Printed Book
SR 263
Inclusive of VAT
Sold as: EACH
SR15Per Month/24 months
Author:Bhadra, Subrata
Date of Publication: 2013
Book classification:Medical Books,English Books,
No. of pages:138 Pages
Format:Paperback

This book is printed on demand and is non-refundable after purchase

Available Formats :

Printed Book

It will be sent to your address

SR263
Incl. VAT

Choose your delivery preference

Or

About this Product

Masters Thesis from the year 2010 in the subject Medicine - Pharmacology, Pharmacy, University of Dhaka (M. Pharm, in Pharmaceutical Technology), language: English, abstract: The aim of the present studies was to develop and characterize 2.6 mg sustained release matrix tablets of Nitroglycerin. Tablets were prepared by direct compression method. Methocel K15M CR and Methocel K100LV CR polymers were used as rate retarding agents in nine formulations (F-1 to F-9). The granules were evaluated for angle of repose, loose bulk density, tapped bulk density, Carrs index, Hausner ratio, moisture content, total porosity and assay. The tablets were subjected to diameter, thickness, assay, uniformity of content, assay after 1Month at 40 C+75%RH, hardness, friability, and in vitro dissolution studies. The granules showed satisfactory flow properties, compressibility, and drug content. All the tablet formulations showed acceptable pharmacotechnical properties and complied with pharmacopoeial specifications for tested parameters. The in vitro dissolution study was carried out for 8 hour using USP-2009 Apparatus-I (Rotating basket method) in distilled water as the dissolution medium. The release mechanisms were explored and explained by Zero order, First order, Higuchi, Korsmeyer-Peppas and Hixson-Crowell equations. Nine formulations were prepared by using three variable ratio of two polymers; Methocel K15M CR (25%, 20% and 15%) and Methocel K100LV CR (15%, 10% and 5%) where all the formulations (F-1 to F-9) contained 0.5% colloidal silicon dioxide and 1% magnesium stearate. Among these nine formulations, six formulations; F-2 (Methocel K15M CR: Methocel K100LV CR = 25%: 10%), F-3 (Methocel K15M CR: Methocel K100LV CR = 25%: 5%), F-4 (Methocel K15M CR: Methocel K100LV CR = 20%: 15%) F-5 (Methocel K15M CR: Methocel K100LV CR = 20%: 10%), F-6 (Methocel K15M CR: Methocel K100LV CR = 20%: 5%) and F-7 (Methocel K15M CR: Methocel K100LV CR = 15%: 15%) met the official specifi
Show more

Specifications

SKU9783656476986
Manufacturer Number9783656476986
year published2013
Show more

Report an issue with this product.

Customer Reviews